Screener
Immunovant, Inc. IMVT Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: Immunovant, Inc.’s 10-Q, filed February 6, 2026.
- Filed
- Feb 6, 2026, 7:24 AM EST
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q4 2025
- Accession
- 0001764013-26-000011
As of December 31, 2025, the Company has authorized 10,010,000 shares of preferred stock, par value $0.0001 per share. Other than the 10,000 shares of preferred stock designated as Series A preferred stock, which are issued and outstanding, there were no issued and outstanding shares of preferred stock as of December 31, 2025.
Item 1. Financial Statements (unaudited)
FAQ
- What is Immunovant, Inc.'s preferred stock, shares authorized?
- Immunovant, Inc. (IMVT) reported preferred stock, shares authorized of $10.01M in Q4 2025.
Ask your AI about Immunovant, Inc.'s preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude